US Sanctions Russian Research Institute that Developed COVID-19 Vaccine

A Russian government spokesperson called the decision “the sanctions theater of the absurd,” Ben Norton reports. 

U.S. Department of Commerce. (Flickr/Ken Lund)

By Ben Norton

Russia won the race to develop the first vaccine against the novel coronavirus. The United States has responded by slapping sanctions on a Russian research facility involved in creating it.

The U.S. government has blacklisted several Russian scientific institutes, including the Russian Defense Ministry’s 48th Central Research Institute, which has worked with other non-military medical centers to develop and test the world’s first Covid-19 vaccine.

In the midst of the global coronavirus pandemic and a historic economic crisis, Washington has escalated its global campaign of economic warfareimposing sanctions on foreign adversaries and announcing new punitive measures on a nearly daily basis.

More than one-fourth of people on Earth live in countries that are suffering from U.S. sanctions.

In April, a Russian company sent ventilators to the United States as a form of humanitarian aid, to help overwhelmed hospitals treat coronavirus patients. It was later revealed that this Russian firm had been under U.S. sanctions since 2014.

State-Led Research Beats US Model 

The Russian government announced this August that it had registered the world’s first Covid-19 vaccine, called Sputnik V.

Sputnik V was developed by the Russian Health Ministry’s Gamaleya Research Institute of Epidemiology and Microbiology. This scientific facility created the vaccine in a joint research project with the Russian Defense Ministry’s 48th Central Research Institute.

On Aug. 27, the U.S. Commerce Department imposed sanctions on Russia’s 48th Central Research Institute, blacklisting the scientific body.

While Russia took a state-led approach to create a coronavirus vaccine, the Trump administration announced a “public-private partnership” in May. The program, called “Operation Warp Speed,” saw the U.S. government dole out billions of tax dollars to Big Pharma companies.

The Trump administration awarded massive contracts to private corporations like NovavaxPfizer, and Moderna, while Trump reportedly offered “large sums of money” for exclusive rights to a vaccine being developed by a German firm so it could be sold for profit.

But the U.S. public-private partnership was unable to develop a vaccine before foreign countries with government-led research efforts did. Besides Russia, a state-owned Chinese company says its vaccine will be ready by the end of 2020, while Cuba is doing clinical trials for a vaccine of its own.

US Blacklists Russian Research Centers 

The U.S. Department of Commerce’s Bureau of Industry and Security announced a series of new sanctions measures on Russian research centers in the U.S.government’s federal register on Aug. 27.

Washington accused the blacklisted institutes of being associated with Russian chemical and biological weapons programs. The Kremlin denied this, calling the accusation “absolute nonsense.”

Russian research institutions sanctioned by the U.S. government on Aug. 27, 2020.

A spokesperson for the Russian government called the decision “the sanctions theater of the absurd.” A Kremlin press release blasted Washington for being unable to “live without sanctions and without declaring restrictions for anyone every day.”

“Given the scientific research of one of the institutes [which is engaged in developing Russia’s coronavirus vaccine] we cannot rule out that this is another example of uncovered and rampant non-competitive struggle,” said the Russian government spokesperson, Dmitry Peskov.

The U.S. government’s media arm, Radio Free Europe / Radio Liberty (RFE/RL), accused these Russian research facilities of developing chemical and biological weapons.

At the same time, RFE/RL acknowledged, “Those targeted by the U.S. Commerce Department include one Russian Defense Ministry facility that is involved in Russia’s attempts to develop the world’s first COVID-19 vaccine.”

RFE/RL explained, “Formally, the move imposes new licensing restrictions on U.S. companies that seek to do business with the blacklisted companies in Russia or elsewhere.”

Russian state media noted that, in addition to being used to conduct clinical trials for the Covid-19 vaccine, the Defense Ministry’s newly blacklisted 48th Central Research Institute is “where vaccines against Ebola and Middle East Respiratory Syndrome (MERS), as well as a universal flu vaccine, had been studied and successfully tested.”

The U.S. sanctions were imposed on the following Russian research institutions:

  • 33rd Scientific Research and Testing Institute
  • 48th Central Scientific Research Institute, Kirov
  • 48th Central Scientific Research Institute, Sergiev Posad
  • 48th Central Scientific Research Institute, Yekaterinburg
  • State Scientific Research Institute of Organic Chemistry and Technology

As the U.S. Commerce Department blacklisted these Russian research facilities, it imposed additional sanctions on two dozen Chinese institutions — mostly construction, technology, and communications companies — accusing them of “engaging in activities contrary to U.S. national security interests.”

Ben Norton is a journalist and writer. He is a reporter for The Grayzone, and the producer of the “Moderate Rebelspodcast,” which he co-hosts with Max Blumenthal. His website is, and he tweets at @BenjaminNorton.

This article is from The Grayzone.

Please Contribute to Consortium News
on its 25th Anniversary

Donate securely with PayPal here

Or securely by credit card or check by clicking the red button: